Epigenetic targeting of autophagy for cancer: DNA and RNA methylation

• Published in: Frontiers in oncology 2023-12, Vol.13, p.1290330-1290330
• Main Authors: Lin, Luobin, Zhao, Yuntao, Zheng, Qinzhou, Zhang, Jiayang, Li, Huaqin, Wu, Wenmei
• Format: Article
• Language: English
• Subjects: 6mA methylation; autophagy; cancers; m6A methylation; Oncology; therapy
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2023.1290330

Autophagy, a crucial cellular mechanism responsible for degradation and recycling of intracellular components, is modulated by an intricate network of molecular signals. Its paradoxical involvement in oncogenesis, acting as both a tumor suppressor and promoter, has been underscored in recent studies. Central to this regulatory network are the epigenetic modifications of DNA and RNA methylation, notably the presence of N6-methyldeoxyadenosine (6mA) in genomic DNA and N6-methyladenosine (m6A) in eukaryotic mRNA. The 6mA modification in genomic DNA adds an extra dimension of epigenetic regulation, potentially impacting the transcriptional dynamics of genes linked to autophagy and, especially, cancer. Conversely, m6A modification, governed by methyltransferases and demethylases, influences mRNA stability, processing, and translation, affecting genes central to autophagic pathways. As we delve deeper into the complexities of autophagy regulation, the importance of these methylation modifications grows more evident. The interplay of 6mA, m6A, and autophagy points to a layered regulatory mechanism, illuminating cellular reactions to a range of conditions. This review delves into the nexus between DNA 6mA and RNA m6A methylation and their influence on autophagy in cancer contexts. By closely examining these epigenetic markers, we underscore their promise as therapeutic avenues, suggesting novel approaches for cancer intervention through autophagy modulation.